Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and therapeutic significance of myeloma genetics and gene expression profiling.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Sept 2005

Stewart A Keith, Fonseca Rafael

Abstract excerpt

Molecular diagnostic tools and novel therapeutics now offer the potential for accurate prognostic and personalized treatment road maps for patients with multiple myeloma (MM). We will review the evidence and provide specific recommendations for routine clinical molecular genetic testing and use o...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Chromosomes, Human, Pair 13
Share to Chromosomes, Human, Pair 14

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Combined Modality Therapy

Share to Cytogenetic Analysis

Share to Multiple Myeloma

Share to Severity of Illness Index

Share to Survival Analysis

Source

Identifiers

PMID: 16155017
DOI: 10.1200/JCO.2005.05.023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16155017-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and therapeutic significance of myeloma genetics and gene expression profiling.PMID 16155017Read ↗

Clinical implications of cytogenetic and molecular aberrations in multiple myelomaSemantic proximity Read ↗

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.Semantic proximity Read ↗

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2Semantic proximity Read ↗

Clinical and biologic implications of recurrent genomic aberrations in myelomaSemantic proximity Read ↗

Clinical implications of chromosomal abnormalities in multiple myelomaSemantic proximity Read ↗

Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.Semantic proximity Read ↗

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.Semantic proximity Read ↗

Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocationSemantic proximity Read ↗

Decoding the pathophysiology and the genetics of multiple myeloma to identify new therapeutic targets.Semantic proximity Read ↗

Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging SystemSemantic proximity Read ↗

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.Semantic proximity Read ↗

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du MyelomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.